Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M107532200 on October 2, 2001

J. Biol. Chem., Vol. 276, Issue 49, 45806-45812, December 7, 2001
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/49/45806    most recent
M107532200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yoo, S. H.
Right arrow Articles by Park, H. Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yoo, S. H.
Right arrow Articles by Park, H. Y.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Localization of Three Types of the Inositol 1,4,5-Trisphosphate Receptor/Ca2+ Channel in the Secretory Granules and Coupling with the Ca2+ Storage Proteins Chromogranins A and B*

Seung Hyun YooDagger, Young Soo Oh, Moon Kyung Kang, Yang Hoon Huh, Seung Ho So, Hyung Seon Park, and Hee Yun Park

From the National Creative Research Initiative Center for Secretory Granule Research, Korea Advanced Institute of Science and Technology, Yu Sung Gu, Dae Jeon, Korea 305-701

Received for publication, August 7, 2001, and in revised form, September 25, 2001

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Although the role of secretory granules as the inositol 1,4,5-trisphosphate (IP3)-sensitive intracellular Ca2+ store and the presence of the IP3 receptor (IP3R)/Ca2+ channel on the secretory granule membrane have been established, the identity of the IP3R types present in the secretory granules is not known. We have therefore investigated the presence of different types of IP3R in the secretory granules of bovine adrenal medullary chromaffin cells using immunogold electron microscopy and found the existence of all three types of IP3R in the secretory granules. To determine whether these IP3Rs interact with CGA and CGB, each IP3R isoform was co-transfected with CGA or CGB into NIH3T3 or COS-7 cells, and the expressed IP3R isoform and CGA or CGB were co-immunoprecipitated. From these studies it was shown that all three types of IP3R form complexes with CGA and CGB in the cells. To further confirm whether the IP3R isoforms and CGA and CGB form a complex in the secretory granules the potential interaction between all three isoforms of IP3R and CGA and CGB was tested by co-immunoprecipitation experiements of the mixture of secretory granule lysates and the granule membrane proteins. The three isoforms of IP3R were shown to form complexes with CGA and CGB, indicating the complex formation between the three isoforms of IP3R and CGA and CGB in the secretory granules. Moreover, the pH-dependent Ca2+ binding property of CGB was also studied using purified recombinant CGB, and it was shown that CGB bound 93 mol of Ca2+/mol with a dissociation constant (Kd) of 1.5 mM at pH 5.5 but virtually no Ca2+ at pH 7.5. The high capacity, low affinity Ca2+-binding property of CGB at pH 5.5 is comparable with that of CGA and is in line with its role as a Ca2+ storage protein in the secretory granules.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The secretory granules of endocrine cells, neurons, and neuroendocrine cells contain many hormones, ions, peptides and proteins, including 40 mM Ca2+ and 1-2 mM chromogranins A and B in addition to high concentrations of hormones (1-6). The secretory granule contents are secreted to the extracellular space and then into the bloodstream during exocytosis, which is initiated by a sudden increase of intracellular Ca2+ concentration (7). In bovine adrenal medullary chromaffin cells the secretory granules occupy ~10% of the total cell volume (8), thereby storing a majority of the intracellular Ca2+ of the cell in the secretory granules. Hence it appears inevitable for the secretory granules to participate in the control of intracellular Ca2+ concentrations.

Consistent with this notion, the secretory granules from adrenal medullary chromaffin cells (9), pancreatic acinar cells (10), and the goblet cells (11) were shown to release stored Ca2+ in response to IP3.1 Using optical sectioning and fluorescent microscope techniques the participation of granular Ca2+ in the control of intracellular Ca2+ concentration has clearly been demonstrated by measuring the Ca2+ concentrations of both the intragranular milieu and of the cytoplasm that is immediately adjacent to the secretory granules simultaneously (11). Moreover, granular Ca2+ was shown to participate in the initiation of exocytosis (12-15), underscoring the importance of granular Ca2+ not only in the control of intracellular Ca2+ concentrations but also in exocytotic processes.

Despite the importance of the IP3-sensitive intracellular Ca2+ store role of secretory granules, the study of IP3R/Ca2+ channels in the secretory granules did not begin until the secretory granule Ca2+ storage protein chromogranin A was shown to interact with several integral secretory granule membrane proteins at pH 5.5, including the IP3R/Ca2+ channel (16). Since then the existence of type 3 IP3R (IP3R-3) in the insulin-containing secretory granules of pancreatic beta -cells had been reported (17) although this study was questioned later due to potential cross-interaction of the IP3R-3-specific antibody used with insulin crystals found in the secretory granules (18). Nevertheless, the existence of IP3R/Ca2+ channels in the secretory granules of insulin-containing pancreatic beta -cells (19) and adrenal medullary chromaffin cells (20) has been confirmed. However the identity of IP3R/Ca2+ channel types present in the secretory granules is unknown. So far three types of IP3R (IP3R-1, -2, and -3) are known to exist, and they interact with each other to form homotetrameric and/or heterotetrameric structures in the native state (21-24), thus forming a Ca2+ channel (25). Each type of IP3R/Ca2+ channel is known to have a different sensitivity to both IP3 and surrounding Ca2+ concentrations (26-32). The IP3 concentration dependence of Ca2+ release of these three types has been shown to be in the order of IP3R-2>IP3R-1>IP3R-3, the type 2 being the most active and type 3 being the least active (27). Moreover, the Ca2+ release property of these channels is shown to be dependent on the surrounding Ca2+ concentrations; the Ca2+ release via the IP3R-1 exhibited a biphasic Ca2+ dependence whereas that of IP3R-3 did not exhibit a biphasic Ca2+ dependence (27-32).

Although the secretory granules of bovine adrenal chromaffin cells contain 40 mM Ca2+, more than 99.9% of the intragranular Ca2+ stays bound to intragranular proteins chromogranins, thus leaving only 24 µM free Ca2+ inside the granules (33). Such low concentrations of intragranular free Ca2+ have also been found in mouse pancreatic acinar cell (10), goblet cell (11), and mast cell (34). Of the chromogranins, chromogranin A and chromogranin B are the two major proteins in virtually all secretory granules of endocrine cells, neurons, and neuroendocrine cells (1-6). For instance, CGA is the most abundant protein in the bovine adrenal medullary chromaffin cells (1-6), whereas CGB is the most abundant protein in human adrenal medullary chromaffin cells (35, 36). Further, CGA is known to bind 55 mol of Ca2+/mol with a Kd of 4 mM at the intragranular pH 5.5 and 32 mol of Ca2+/mol with a dissociation constant (Kd) of 2.7 mM at a near physiological pH 7.5 (37). The high capacity, low affinity Ca2+ binding property of CGA has been proposed to be responsible for the IP3-sensitive Ca2+ store role of secretory granules of bovine adrenal medullary chromaffin cells (9, 37).

We have previously demonstrated direct interaction between the IP3R-1 and CGA and CGB using purified IP3R-1 (20). Furthermore, coupling of CGA and CGB with the IP3R-1 was shown to enhance the IP3-induced Ca2+ release through the IP3R-1/Ca2+ channel reconstituted in the liposomes (38). In addition, the open probability and mean open time of the IP3R-1/Ca2+ channel were also shown to increase in the lipid bilayer as a result of coupled CGA (39). We have therefore investigated in the present study the identity of IP3R types that are present in the secretory granules and the pH-dependent Ca2+-binding property of CGB. Moreover, the potential interaction between each IP3R type and the secretory granule Ca2+ storage proteins chromogranins A and B was also studied.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Antibodies-- Production of polyclonal anti-rabbit CGA and CGB antibodies were raised against intact bovine CGA and recombinant CGB. Monoclonal hemagglutinin (HA) antibody was from Roche Molecular Biochemicals. IP3R peptides specific to the terminal 10-13 amino acids of type 1 (HPPHMNVNPQQPA), type 2 (SNTPHENHHMPPA), and type 3 (FVDVQNCMSR) were synthesized with a carboxyl-terminal cysteine, and anti-rabbit polyclonal antibodies were raised. The polyclonal anti-rabbit antibodies were affinity purified on each immobilized peptide following the procedure described for the IP3R antibody production (16). Monoclonal anti-bovine CGB antibody was produced following a standard procedure.

Purification of IP3R Isoforms from Cerebellum-- Purification of bovine type 1, 2, and 3 IP3R was carried out following the procedure described previously (20) except that an isoform-specific antibody-coupled immunoaffinity column was used in each case. The purified bovine cerebellum IP3Rs bound ~300-320 pmol of IP3/mg of protein as determined according to the published method (21).

Immunocytochemical Localization of IP3R-1, -2, and -3 in Adrenal Chromaffin Cells-- Tissue samples from bovine adrenal medulla were fixed for 2 h at 4 °C in PBS containing 0.1% glutaraldehyde, 4% paraformaldehyde, and 3.5% sucrose. After three washes in PBS, the tissues were postfixed with 1% osmium tetroxide on ice for 2 h, washed three times, and stained en block with 0.5% uranyl acetate, all in PBS. The tissues were then embedded in Epon 812 after dehydration in an ethanol series. Ultrathin sections were collected on Formvar/carbon-coated nickel grids, which were then floated on drops of freshly prepared 3% sodium metaperiodate (40) for 30 min. The immunogold labeling procedure was modified from Spector et al. (41) and the manufacturer's recommended protocol (British Biocell International). After etching and washing, the grids were placed on 50-µl droplets of solution A (phosphate saline solution, pH 8.2, containing 4% normal goat serum, 1% bovine serum albumin, 0.1% Tween 20, 0.1% sodium azide) for 30 min. Grids were then incubated for 2 h at room temperature in a humidified chamber on 50-µl droplets of each type-specific anti-rabbit IP3R antibody appropriately diluted in solution B (solution A but with 1% normal goat serum), followed by rinses in solution B. The grids were reacted with 10-nm gold-conjugated goat anti-rabbit IgG diluted in solution A. Controls for the specificity of IP3R immunogold labeling included 1) omitting the primary antibody, and 2) replacing the primary antibody with preimmune serum. After washes in PBS and deionized water, the grids were stained with uranyl acetate (7 min) and lead citrate (2 min), and were viewed with a Zeiss EM912 electron microscope.

Co-transfection and Co-immunoprecipitation of IP3R-2 or -3 and CGA or CGB-- The full-length cDNAs for bovine IP3R type 2 (Y. S. Oh, M. K. Kang and S. H. Yoo, GenBankTM accession no. AF402600) and type 3 (M. K. Kang, Y. S. Oh, and S. H. Yoo, GenBankTM accession no. AF402601) were subcloned into the vector pcDNA 3.1(+) and tagged with HA to create recombinant plasmid pc-b2 and -b3. NIH3T3 and COS-7 cells, along with CGA expressing pCI-CGA (42) and CGB expressing pCI-CGB (43) cells, were cultured in DMEM medium supplemented with 10% fetal bovine serum. The pc-b2 or -b3 was co-transfected either into NIH3T3 cells along with CGA expressing pCI-CGA, or into COS-7 cells along with CGB expressing pCI-CGB. Expression of IP3R-2 or IP3R-3 as well as CGA or CGB in NIH3T3 and COS-7 cells was confirmed by Western blot analysis (not shown). The rest of the co-immunoprecipitation experiments followed the procedure described for the co-transfection and co-immunoprecipitation of IP3R-1 and CGA or CGB (20).

Co-immunoprecipitation of Three Isoforms of IP3R and CGA and CGB from Secretory Granules of Bovine Adrenal Chromaffin Cells-- To perform co-immunoprecipitation experiments, 20 µg of secretory granule lysate proteins and 200 µg of secretory granule membrane proteins (16) were mixed first in 220 µl of the pH 5.5 buffer (20 mM sodium acetate, pH 5.5, 0.1 M KCl, and 0.1% Triton X-100). The mixture was precleaned by incubating with protein A-Sepharose for 1 h at 4 °C, followed by centrifugation at 22,000 × g for 5 min. Immunoprecipitation was carried out using the supernatant (~200 µl) by incubating with 10 µl (1 µg/µl) of the polyclonal anti-rabbit CGB antibody for 1 h at 4 °C. Then 15 µl of a 1:1 slurry of protein A-Sepharose in the pH 5.5 buffer was added to the mixture and incubated for 1 h. The complexes were pelleted by centrifugation at 3,500 × g for 1 min, and the immunoprecipitate was washed five times with the pH 5.5 buffer. The bound proteins were separated on 7.5% SDS-polyacrylamide gels and subjected to immunoblot analysis using each isoform-specific IP3R antibodies and monoclonal CGB and polyclonal CGA antibodies.

Purification of Recombinant CGB and Ca2+ Binding Study-- Recombinant bovine CGB was expressed in Escherichia coli and purified as described (42). For the CGB Ca2+ binding study, purified recombinant CGB (5 mg) was coupled to 0.2 g of cyanogen bromide-activated Sepharose 4B according to the method suggested by the manufacturer (Amersham Pharmacia Biotech). The amount of CGB coupled to Sepharose 4B was determined by extracting by a strong alkali treatment as described previously (20). Upon completion of the coupling, it was estimated that 1 mg of CGB was coupled to 1 ml (wet volume) of Sepharose 4B, and this was used for 45Ca2+ binding studies. The Ca2+ binding studies were carried out according to the procedure described for the Ca2+ binding to CGA (20).

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Specificity of Isoform-specific IP3R Antibodies-- To determine whether each IP3R antibody interacts with each isoform-specific IP3R, the proteins that interact with each isoform-specific IP3R antibody were purified from bovine cerebellum using each isoform-specific antibody-coupled immunoaffinity column (Fig. 1A). Visualization of the purified proteins on an SDS-polyacrylamide gel showed proteins with molecular sizes of 260-280 kDa (Fig. 1A); the proteins purified by type 1 and type 3 specific antibodies were shown in a ~280-kDa region while the protein purified by the type 2-specific antibody was shown in a ~260-kDa region, indicating that each IP3R isoform-specific antibody interacted with different proteins in the 260-280 kDa range. These proteins were shown to bind 300-320 pmol of IP3/mg as determined by a method described previously (21), thus confirming them as IP3Rs.


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 1.   SDS-polyacrylamide gel electrophoresis and immunoblot analysis of purified IP3R isoforms. IP3R isoforms purified from bovine cerebellum using each isoform-specific antibody-coupled immunoaffinity column were separated on a 7.5% SDS-polyacrylamide gel (30 ng/lane) and visualized with silver-staining (A). The identical gels were also subjected to immunoblot analysis using type 1, 2, and 3 specific IP3R antibodies (B). Lane 1, type 1 IP3R; lane 2, type 2 IP3R; lane 3, type 3 IP3R. Note that each type of IP3R reacted only with its isoform-specific antibody.

To further determine whether each of the purified proteins interact with only one isoform-specific IP3R antibody or not, the purified IP3Rs were separated on 7.5% SDS-polyacrylamide gels and subjected to immunoblot analysis using each isoform-specific IP3R antibody. Results in Fig. 1B show that the different IP3R isoform purified reacts only with the IP3R antibody with which it is purified and not with other isoform-specific IP3R antibodies, thus demonstrating the isoform-specific nature of the IP3R antibodies used.

Subcellular Localization of IP3R-1, -2, and -3-- To determine the subcellular location of each type of IP3R in the adrenal medullary chromaffin cells, immunogold cytochemistry was carried out with bovine adrenal medulla using each IP3R type-specific antibody (Fig. 2, A-C). As shown in Fig. 2A, the IP3R type I (IP3R-1)-reacting gold particles were localized in the secretory granules whereas none of the gold particles was localized in the mitochondria. More than half of the gold particles found in the secretory granules are localized in the periphery of the secretory granules along the secretory granule membrane, consistent with the known location of the IP3R on the secretory granule membrane (20).


View larger version (65K):
[in this window]
[in a new window]
 
Fig. 2.   Immunogold localization with affinity-purified IP3R type 1, 2, and 3 antibodies. Bovine adrenal medullary chromaffin cells were immunolabeled for type 1, 2, and 3 IP3R (10 nm) with each isoform-specific affinity-purified IP3R antibodies. Majority of the IP3R-1 (A), IP3R-2 (B), and IP3R-3 labeling (C) gold particles are localized on or near the membrane region of the secretory granules (SG). The gold particles are also localized in the endoplasmic reticulum (rer) but not in the mitochondria (M). Bar, 200 nm.

To further determine the presence of IP3R type 2 (IP3R-2) in the secretory granules, the IP3R-2-specific antibody was used in the immunogold cytochemistry (Fig. 2B). The IP3R-2-reacting gold particles were primarily localized on the secretory granule membranes whereas no gold particles were found in the mitochondria (Fig. 2B). In a similar study using IP3R type 3- (IP3R-3) specific antibody (Fig. 2C), the IP3R-3-reacting gold particles were also shown to localize in the secretory granules of bovine adrenal medullary chromaffin cells, more than half of the gold particles localizing on the periphery of the secretory granules (Fig. 2C).

In parallel control experiments that had been carried out either without the primary antibody or with preimmune serum, virtually no gold particles were found in the identical chromaffin cell tissues (not shown), further demonstrating the specificity of the immunogold labeling.

To ensure that the IP3R antibodies react specifically with the IP3R on the secretory granule membrane and that each type-specific IP3R antibody react specifically with the corresponding IP3R type, the secretory granule membrane proteins from bovine adrenal medulla were separated on a 7% SDS-polyacrylamide gel and subjected to immunoblot analysis using each type-specific IP3R antibody (Fig. 3). The IP3R-1-specific antibody reacted exclusively with a ~280-kDa secretory granule membrane protein, suggesting that the IP3R-1 antibody used in the present study specifically reacted with the IP3R-1 on the secretory granule membrane. Similarly, antibodies specific for IP3R-2 and -3 also reacted with a ~260-kDa and a ~280-kDa protein, respectively, on the secretory granule membrane (Fig. 3), indicating that the IP3R antibodies used in the present study specifically reacted with different IP3Rs on the secretory granule membrane protein. Some of the type 2 IP3R appeared to be degraded as an ~83-kDa protein also reacted with the antibody.


View larger version (65K):
[in this window]
[in a new window]
 
Fig. 3.   Immunoblot of the secretory granule integral membrane proteins with each type-specific IP3R antibody. 70 µg of secretory granule integral membrane proteins from bovine adrenal medullary chromaffin cells were separated on a 7% SDS-polyacrylamide gel and were probed with the same each type-specific IP3R (IP3R-1, -2, and -3) antibodies used in the immunogold cytochemical studies. 10 µg of integral membrane proteins were visualized with Coomassie Blue staining (memb. prot.), and the immunoblot results obtained with the IP3R-1 (type 1), IP3R-2 (type 2), and IP3R-3 (type 3) antibodies are shown. A 260-280-kDa membrane protein specifically reacted with each IP3R antibody.

Complex Formation between the IP3R-1, -2, and -3 and Chromogranins A and B-- We have previously demonstrated the physical interaction between the IP3R-1 and CGA and CGB (24). However, the potential physical interactions between the chromogranins and either the IP3R-2 or the IP3R-3 have not been studied. Hence, to determine whether the IP3R-2 and chromogranins A and B are physically linked in the cells, each type of IP3R and CGA or CGB were co-transfected into NIH3T3 or COS-7 cells and co-immunoprecipitation was carried out (Figs. 4 and 5). As shown in Fig. 4, A and B, immunoprecipitation of the NIH3T3 cell extracts, which had been co-transfected with IP3R-2 and CGA, by monoclonal HA antibody and immunoblot analysis by CGA and HA antibodies (Fig. 4A) indicated the co-immunoprecipitation of the IP3R-2 and CGA. Moreover, immunoprecipitation of the same cell extracts with CGA antibody and immunoblot analysis by CGA and HA antibodies (Fig. 4B) also indicated the co-precipitation of CGA and IP3R-2, demonstrating the complex formation between the IP3R-2 and CGA in the cell. Furthermore, in similar experiments NIH3T3 cells were co-transfected with the IP3R-3 and CGA to determine the complex formation between the IP3R-3 and CGA. As shown in Fig. 4, C and D, immunoprecipitation of the NIH3T3 cell extracts that had been co-transfected with the IP3R-3 and CGA by monoclonal HA antibody and immunoblot analysis by CGA and HA antibodies (Fig. 4C) indicated the co-immunoprecipitation of the IP3R-3 and CGA. Further, immunoprecipitation of the same cell extracts with CGA antibody and immunoblot analysis by CGA and HA antibodies (Fig. 4D) also indicated the co-precipitation of CGA and IP3R-3, indicating the complex formation between the IP3R-3 and CGA in the cell. Identical results were also obtained with COS-7 cells.


View larger version (27K):
[in this window]
[in a new window]
 
Fig. 4.   Co-immunoprecipitation of CGA with IP3R-2 or -3. A and B, protein extracts from NIH3T3 cells, which had been cotransfected with HA-tagged IP3R-2 and CGA were immunoprecipitated with monoclonal HA antibody (mHA Ab). The immunoprecipitates were separated on a 7.5% SDS gel and were immunoblotted with anti-CGA antibody (CGA Ab) (upper panel) and mHA Ab (lower panel), respectively (A). The same extracts were immunoprecipitated with CGA antibody and immunoblotted with mHA Ab (upper panel) and CGA antibody (lower panel) (B). C and D, protein extracts from NIH3T3 cells which had been cotransfected with HA-tagged IP3R-3 and CGA were immunoprecipitated with monoclonal HA antibody (mHA Ab). The immunoprecipitates were separated on a 7.5% SDS-gel and were immunoblotted with anti-CGA antibody (CGA Ab) (upper panel) and mHA Ab (lower panel), respectively (C). Same extracts were immunoprecipitated with CGA antibody and immunoblotted with mHA Ab (upper panel) and CGA antibody (lower panel) (D). Preimmune IgG was used as control antibody (lane 1). 260 kDa IP3R-2 and 280 kDa IP3R-3 were co-immunoprecipitated with 75 kDa CGA.


View larger version (24K):
[in this window]
[in a new window]
 
Fig. 5.   Co-immunoprecipitation of CGB with IP3R-2 or -3. A and B, protein extracts from COS-7 cells, which had been cotransfected with HA-tagged IP3R-2 and CGB were immunoprecipitated with monoclonal HA antibody (mHA Ab), and were immunoblotted with anti-CGB antibody (CGB Ab) (upper panel) and mHA Ab (lower panel), respectively (A). Same extracts were immunoprecipitated with CGB antibody and immunoblotted with mHA Ab (upper) and CGB antibody (lower) (B). C and D, protein extracts from COS-7 cells, which had been cotransfected with HA-tagged IP3R-3 and CGB were immunoprecipitated with monoclonal HA antibody (mHA Ab), and were immunoblotted with anti-CGB antibody (CGB Ab) (upper panel) and mHA Ab (lower panel), respectively (C). The same extracts were immunoprecipitated with CGB antibody and immunoblotted with mHA Ab (upper) and CGB antibody (lower) (D). Preimmune IgG was used as control antibody (lane 1). 260 kDa IP3R-2 and 280 kDa IP3R-3 were co-immunoprecipitated with 105 kDa CGB.

Similarly, immunoprecipitation of the COS-7 cell extracts, which had been co-transfected with the IP3R-2 and CGB, by monoclonal HA antibody and immunoblot analysis by CGB and HA antibodies (Fig. 5A) indicated the co-precipitation of CGB and IP3R-2. Immunoprecipitation of the same cell extracts with CGB antibody and immunoblot analysis by IP3R-2 and CGB antibodies (Fig. 5B) also indicated the co-precipitation of CGB and IP3R-2, further demonstrating the complex formation between the IP3R-2 and CGB in the cell. Likewise, immunoprecipitation of the COS-7 cell extracts that had been co-transfected by the IP3R-3 and CGB by monoclonal HA antibody and immunoblot analysis by CGB and HA antibodies (Fig. 5C) indicated the co-precipitation of CGB and IP3R-3. Moreover, immunoprecipitation of the same cell extracts with CGB antibody and immunoblot analysis by IP3R-3 and CGB antibodies (Fig. 5D) also indicated the co-precipitation of CGB and IP3R-3, again demonstrating the complex formation between the IP3R-3 and CGB in native state. Again, identical results were also obtained with NIH3T3 cells, further suggesting the universal nature of complex formation between the IP3Rs and chromogranins A and B.

To further determine whether all three isoforms of IP3R form complexes with CGA and CGB in the secretory granules of adrenal chromaffin cells, the mixture of secretory granule lysate proteins and the granule membrane proteins of bovine adrenal chromaffin cells was immunoprecipitated with polyclonal anti-rabbit CGB antibody. The presence of each isoform-specific IP3R, along with CGA and CGB, in the immunoprecipitate was tested using each isoform-specific IP3R antibodies and monoclonal CGB and polyclonal CGA antibodies (Fig. 6). As shown in Fig. 6, immunoprecipitation of the secretory granule proteins by polyclonal anti-rabbit CGB antibody precipitated all three types of IP3R (A, type 1; B, type 2; C, type 3) in addition to CGA and CGB, clearly demonstrating the complex formation between all three types of IP3R and CGA and CGB in the secretory granules of adrenal chromaffin cells.


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 6.   Co-immunoprecipitation of all three isoforms of IP3R and CGA with CGB in the secretory granule proteins of bovine adrenal chromaffin cells. The mixture of 20 µg of secretory granule lysate proteins and 200 µg of secretory granule membrane proteins were immunoprecipitated with 10 µg of polyclonal anti-rabbit CGB antibody, and the immunoprecipitates were analyzed by immunoblotting for the presence of IP3R-1 (A), -2 (B), and -3 (C) using each isoform-specific antibodies, and polyclonal CGA and monoclonal CGB antibodies.

Ca2+ Binding to CGB-- Although the pH-dependent low affinity, high capacity Ca2+ binding property of CGA has been determined before (37), the low affinity, high capacity Ca2+ binding property of CGB remained to be determined. To determine the Ca2+ binding property of CGB, we have first expressed bovine CGB in E. coli and obtained large amounts of purified recombinant CGB as described (43). One of the difficulties of determining the Ca2+ binding property of CGB was its tendency to aggregate in the presence of Ca2+ (44). To avoid the aggregation problem, CGB was first coupled to Sepharose 4B before measuring its Ca2+ binding property. As shown in Fig. 7A, Ca2+ binding to the immobilized CGB showed drastically different pH-dependent profiles. Large amounts of Ca2+ bound to CGB at the intragranular pH 5.5 and the Ca2+ binding profile indicated saturation as the free Ca2+ concentration increased. In contrast, there was virtually no Ca2+ binding to CGB at a near physiological pH 7.5. Scatchard analysis (45) of the binding result (Fig. 7B) showed that CGB bound 93 mol of Ca2+/mol (1290 nmol of Ca2+/mg) at pH 5.5 with a dissociation constant (Kd) of 1.5 mM. Although another high capacity, low affinity Ca2+-binding protein CGA is also known to bind more Ca2+ at pH 5.5 than at pH 7.5 (37), the drastic difference in the Ca2+ binding property of CGB at the two pH levels is surprising. Given that the acidic pH is expected to reduce ionic interaction between negatively charged acidic protein CGB and positively charged calcium ions, the high capacity Ca2+ binding to CGB at pH 5.5 appears to be due to the CGB conformation at the acidic pH.


View larger version (12K):
[in this window]
[in a new window]
 
Fig. 7.   Binding of Ca2+ to chromogranin B immobilized on Sepharose 4B and Scatchard analysis. 45Ca2+ binding to CGB coupled to Sepharose 4B was measured at pH 5.5 and pH 7.5 and was analyzed according to Scatchard (45). Buffers used were either 20 mM sodium acetate, pH 5.5, 0.1 M KCl, or 20 mM Tris-HCl, pH 7.5, 0.1 M KCl. A, binding to 45Ca2+ to CGB was measured as described previously (37). Data are means ± S.E. of three representative experiments at pH 5.5 () and pH 7.5 (open circle ). B, Scatchard analysis of the Ca2+ binding data at pH 5.5 in panel A. Chromogranin B bound 1290 nmol of Ca2+/mg (93 mol of Ca2+/mol) with a Kd of 1.5 mM at pH 5.5. B/F, bound/free.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Since the demonstration that the secretory granules of adrenal medullary chromaffin cells release Ca2+ in response to IP3 (9), the IP3-sensitive Ca2+ store role of secretory granules has also been shown in other secretory cells (10, 11). The presence of IP3R on the secretory granule membrane has been shown in adrenal chromaffin cells (16, 20) and pancreatic beta -cells (19). Further, the IP3R was demonstrated to co-localize with chromogranin A in the secretory granules of bovine adrenal medullary chromaffin cells (20). Nevertheless, it was not known what isoforms of IP3R exist on the secretory granule membrane. Present results demonstrate the presence of all three types of IP3R in the secretory granules of bovine adrenal medullary chromaffin cells (Fig. 2). By co-transfection of IP3R-1 and CGA or CGB into COS-7 cells, followed by co-immunoprecipitation of the expressed proteins, we have shown previously that the IP3R-1 and CGA or CGB form complexes in the cell (20). Likewise, co-transfection and co-immunoprecipitation studies using the IP3R-2, -3 and chromogranins A and B further demonstrated the complex formation between CGA and the IP3R-2 or -3 (Fig. 4) and between CGB and the IP3R-2 or -3 (Fig. 5). The complex formation between the IP3Rs and chromogranins A and B appeared to be an intrinsic property of these Ca2+ channel and Ca2+ storage proteins, reflecting the functional coupling in the secretory granules of secretory cells. It is hence of great importance that the results in Fig. 6 clearly demonstrate that the secretory granules of bovine adrenal chromaffin cells not only contain all three isoforms of IP3R but also they form complexes with CGA and CGB. This is the first time that chromogranins A and B were shown to form complexes with all three isoforms of IP3R in native state. The widespread presence of CGA and CGB in the secretory granules of secretory cells appears to strongly imply the physiological importance of the coupling between the IP3Rs and the Ca2+ storage proteins in neurons, endo/exocrine cells, and neuroendocrine cells.

In line with this importance, the coupling of CGA with the IP3R was indeed shown to modulate the IP3R/Ca2+ channel function (38). Using liposomes incorporated with the purified IP3R-1 in the presence and absence of encapsulated CGA, it was found that the coupled CGA changed the conformation of IP3R-1 such that more IP3 bound to the incorporated IP3R-1 and more Ca2+ were released from the proteoliposomes in the presence of coupled CGA (38). The IP3R/Ca2+ channel modulatory role of CGA was observed only when the intraliposomal pH was maintained at 5.5 (38), the intragranular pH at which the IP3R and CGA remain coupled (16, 20). But when the intraliposomal pH was changed to 7.5, CGA failed to exhibit any effect (38) due to its dissociation from the IP3R/Ca2+ channel (16, 20). It was further shown that the open probability and mean open time of the IP3R/Ca2+ channel were markedly increased in the presence of coupled CGA as determined by single channel recordings using lipid bilayers (39). But when CGA was decoupled from the IP3R/Ca2+ channel by changing the pH from 5.5 to 7.5, the mean open time and open probability of the IP3R/Ca2+ channel returned to the levels obtained in the absence of CGA (39).

In addition to the increased binding of IP3 and the conformational change of the IP3R/Ca2+ channel as a result of CGA coupling, our preliminary results also suggested that the IP3 sensitivity of the IP3R/Ca2+ channel increases at least 5-fold in the presence of coupled CGA, i.e. 5-fold less IP3 is needed to induce release of same amount of Ca2+ in the presence of coupled CGA than in the absence.2 Moreover, the IP3R/Ca2+ channel modulatory effect of CGA was also similarly exhibited by CGB.2 From these results it appears that the coupled Ca2+ storage proteins CGA and CGB directly modulate the IP3R/Ca2+ channel such that not only the IP3-mediated Ca2+ release property but also the IP3 sensitivity of the IP3R/Ca2+ channels are altered. In light of the fact that chromogranins are most abundant in the secretory granules, it is likely that the secretory granules will be more sensitive to IP3 than other organelles such as the ER and nucleus. Interestingly, it has continuously been shown that despite the presence of IP3R/Ca2+ channels in the nucleus (46, 47), endoplasmic reticulum (21-32), and secretory granules, a given dose of IP3 does not necessarily evoke a uniform release of Ca2+ from these organelles (29). This difference in the amount of Ca2+ released from each IP3 sensitive store in response to a same concentration of IP3 is likely to be influenced by the presence or absence of chromogranins inside the IP3R/Ca2+-containing organelles.

In this regard, the example of different sensitivity of IP3 sensitive intracellular Ca2+ store to IP3 has clearly been shown in the case of pancreatic acinar cell (10, 48, 49). The pancreatic acinar cell is highly polarized that all the zymogen granules are localized in the apical secretory granule region whereas the endoplasmic reticulum and nucleus are localized in the basal region of the cell (50). The ER-rich, nucleus-containing cytoplasmic area encircles the apical granule region where the cluster of zymogen granules is found. Due to this kind of highly polarized morphology of pancreatic acinar cells, any IP3 that is produced at a localized plasma membrane region away from the granule area should travel through the ER-rich, nucleus-containing cytoplasm before it can reach the secretory granule area. Indeed, exposure of pancreatic acinar cells to the IP3-producing agonist such as acetylcholine and cholecystokinin has been shown to release Ca2+ from the secretory granule area first although the IP3-producing agonist was applied to the cell surface far removed from the secretory granule-rich area of the cell (10, 48, 49). Therefore, the release of Ca2+ from the secretory granules of pancreatic acinar cell, ahead of the ER and nucleus (10, 48, 49), clearly demonstrates the fact that the secretory granules are more sensitive to IP3 than the ER or the nucleus.

In line with the high capacity, low affinity Ca2+ binding property of CGA at two different conformations (37), CGB also bound 93 mol of Ca2+/mol with a Kd of 1.5 mM at pH 5.5, but bound virtually no Ca2+ at pH 7.5 (Fig. 7). These results clearly point out a close relationship between the Ca2+ binding property and the conformation of chromogranins A and B. Considering that binding of IP3 to the IP3R/Ca2+ channel is known to change the conformation of the IP3R/Ca2+ channel (51), it is natural to assume that the conformational change of the IP3R/Ca2+ channel that results from IP3 binding will automatically be transmitted to the coupled chromogranins, which in turn could lead not only to the change in conformation of the chromogranins but also to the change in affinity for Ca2+. This change in affinity for Ca2+ is expected to change the free Ca2+ concentrations inside the secretory granules instantaneously, probably changing from low to high free Ca2+ concentrations. Therefore, given the large amount of calcium (40 mM) in the secretory granule the sudden dissociation of even a small fraction of the bound Ca2+ from the chromogranins is likely to produce a relatively high free Ca2+ concentration that could be released into the cytoplasm through the IP3R/Ca2+ channels. Given the direct physical coupling between the IP3R/Ca2+ channels and the Ca2+ storage proteins CGA and CGB in the secretory granules, the whole train of events from the binding of IP3 to the release of Ca2+ is expected to take place very fast, in accordance with the fast stimulus secretion responses of secretory cells.

In light of the lack of other examples of direct coupling between an ion channel and its cognate ion storage protein, the coupling between the IP3R/Ca2+ channel and chromogranins A and B stands out as the only known example of direct coupling between an ion channel and its cognate ion storage protein. In particular, in view of the fact that the IP3R/Ca2+ channel exists as homo- and/or heterotetrameric structure (21-24) and that chromogranins A and B can also exist either in homotetrameric CGA (52, 53) or in heterotetrameric CGA2CGB2 structure (54), the coupling between these two classes of proteins presents the possibility of coupling between tetrameric IP3R/Ca2+ channel and tetrameric chromogranin (54). In this regard, the present results demonstrating the complex formation between all three types of IP3R/Ca2+ channels and chromogranins A and B in the secretory granules further underscore this possibility. Given that the IP3R/Ca2+ channels in the cell respond differently even to same amount of IP3 (26-32) our present results shed further light on the molecular structural basis of why the IP3R/Ca2+ channels respond differently to a given concentration of IP3 in the cell.

Although the ER also contains calreticulin, which is a high capacity, low affinity Ca2+ storage protein (55), binding 25-50 mol of Ca2+/mol with a Kd of 1-2 mM (56-58), it is not known whether calreticulin is directly coupled to the IP3R/Ca2+ channel in the ER. Calreticulin is estimated to represent 1-2% of total microsomal proteins (57), whereas chromogranins A and B account for more than 20% of the secretory granule proteins (1, 5). Moreover, the total ER calcium concentration of ~3 mM (59) is far lower than 40 mM Ca2+ in the secretory granules (1, 2, 33). Hence, these facts further highlight the need for cells to better control the intracellular Ca2+ concentrations through fine-tuning of the Ca2+ storage/release mechanisms of the secretory granules. In this respect, the existence of all three types of IP3R/Ca2+ channel and the abundant presence of Ca2+ storage proteins chromogranins A and B in the secretory granules will be pivotal for the secretory granules in fine-tuning the intracellular Ca2+ concentrations in the secretory cells.

    FOOTNOTES

* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AF402600 and AF402601.

Dagger To whom correspondence should be addressed. Tel.: 82-42-869-8279; Fax: 82-42-869-8280; E-mail: shyoo@kaist.ac.kr.

Published, JBC Papers in Press, October 2, 2001, DOI 10.1074/jbc.M107532200

2 S. H. Yoo and S. H. So, unpublished results.

    ABBREVIATIONS

The abbreviations used are: IP3, inositol 1,4,5-trisphosphate; IP3R, inositol 1,4,5-trisphosphate receptor; CGA, chromogranin A; CGB, chromogranin B; ER, endoplasmic reticulum; HA, hemagglutinin; PBS, phosphate-buffered saline.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Winkler, H., and Westhead, E. (1980) Neuroscience 5, 1803-1823[CrossRef][Medline] [Order article via Infotrieve]
2. Hutton, J. C. (1989) Diabetologia 32, 271-281[CrossRef][Medline] [Order article via Infotrieve]
3. Simon, J.-P., and Aunis, D. (1989) Biochem. J. 262, 1-13[Medline] [Order article via Infotrieve]
4. Helle, K. B. (1990) Neurochem. Int. 17, 165-175[CrossRef]
5. Winkler, H., and Fischer-Colbrie, R. (1992) Neuroscience 49, 497-528[CrossRef][Medline] [Order article via Infotrieve]
6. Iacangelo, A. L., and Eiden, L. E. (1995) Regulat. Pept. 58, 65-88
7. Chen, Y. A., Scales, S. J., Duvvuri, V., Murthy, M., Patel, S. M., Schulman, H., and Scheller, R. H. (2001) J. Biol. Chem. 276, 26680-26687[Abstract/Free Full Text]
8. Nordmann, J. J. (1984) J. Neurochem. 42, 434-437[CrossRef][Medline] [Order article via Infotrieve]
9. Yoo, S. H., and Albanesi, J. P. (1990) J. Biol. Chem. 265, 13446-13448[Abstract/Free Full Text]
10. Gerasimenko, O. V., Gerasimenko, J. V., Belan, P. V., and Petersen, O. H. (1996) Cell 84, 473-480[CrossRef][Medline] [Order article via Infotrieve]
11. Nguyen, T., Chin, W.-C., and Verdugo, P. (1998) Nature 395, 908-912[CrossRef][Medline] [Order article via Infotrieve]
12. Maruyama, Y., Inooka, G., Li, Y. X., Miyashita, Y., and Kasai, H. (1993) EMBO J. 12, 3017-3022[Medline] [Order article via Infotrieve]
13. Maruyama, Y., and Petersen, O. H. (1994) Cell Calcium 16, 419-430[CrossRef][Medline] [Order article via Infotrieve]
14. Mundorf, M. L., Hochstetler, S. E., and Wightman, R. M. (1999) J. Neurochem. 73, 2397-2405[CrossRef][Medline] [Order article via Infotrieve]
15. Mundorf, M. L., Troyer, K. P., Hochstetler, S. E., Near, J. A., and Wightman, R. M. (2000) J. Biol. Chem. 276, 9136-9142
16. Yoo, S. H. (1994) J. Biol. Chem. 269, 12001-12006[Abstract/Free Full Text]
17. Blondel, O., Moody, M. M., Depaoli, A. M., Sharp, A. H., Ross, C. A., Swift, H., and Bell, G. I. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 7777-7781[Abstract/Free Full Text]
18. Ravazzola, M., Halban, P. A., and Orci, L. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 2745-2748[Abstract/Free Full Text]
19. Srivastava, M., Atwater, I., Glasman, M., Leighton, X., Goping, G., Caohuy, H., Miller, G., Pichel, J., Westphal, H., Mears, D., Rojas, E., and Pollard, H. B. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 13783-13788[Abstract/Free Full Text]
20. Yoo, S. H., So, S. H., Kweon, H. S., Lee, J. S., Kang, M. K., and Jeon, C. J. (2000) J. Biol. Chem. 275, 12553-12559[Abstract/Free Full Text]
21. Maeda, N., Niinobe, M., and Mikoshiba, K. (1990) EMBO J. 9, 61-67[Medline] [Order article via Infotrieve]
22. Monkawa, T., Miyawaki, A., Sugiyama, T., Yoneshima, H., Yamamoto-Hino, M., Furuich, T., Saruta, T., Hasegawa, M., and Mikoshiba, K. (1995) J. Biol. Chem. 270, 14700-14704[Abstract/Free Full Text]
23. Joseph, S. K., Lin, C., Pierson, S., Thomas, A. P., and Maranto, A. R. (1995) J. Biol. Chem. 270, 23310-23316[Abstract/Free Full Text]
24. De Smedt, H., Missiaen, L., Parys, J. B., Henning, R. H., Sienaert, I., Vanlingen, S., Gijsens, A., Himpens, B., and Casteels, R. (1997) Biochem. J. 322, 575-583
25. Ferris, C. D., Huganir, R. L., Supattapone, S., and Snyder, S. H. (1989) Nature 42, 87-89
26. Mak, D.-O. D., McBride, S., and Foskett, J. K. (1999) J. Biol. Chem. 274, 22231-22237[Abstract/Free Full Text]
27. Miyakawa, T., Maeda, A., Yamazawa, T., Hirose, K., Kurosaki, T., and Iino, M. (1999) EMBO J. 18, 1303-1308[CrossRef][Medline] [Order article via Infotrieve]
28. Ramos-Franco, J., Fill, M., and Mignery, G. A. (1998) Biophys. J. 75, 834-839[Medline] [Order article via Infotrieve]
29. Taylor, C. W. (1998) Biochim. Biophys. Acta 1436, 19-33[Medline] [Order article via Infotrieve]
30. Bezprozvanny, I., Watras, J., and Ehrlich, B. E. (1991) Nature 351, 751-754[CrossRef][Medline] [Order article via Infotrieve]
31. Hagar, R. E., Burgstahler, A. D., Nathanson, M. H., and Ehrlich, B. E. (1998) Nature 396, 81-84[CrossRef][Medline] [Order article via Infotrieve]
32. Adkins, C. E., and Taylor, C. W. (1999) Curr. Biol. 9, 1115-1118[CrossRef][Medline] [Order article via Infotrieve]
33. Bulenda, D., and Gratzl, M. (1985) Biochemistry 24, 7760-7765[CrossRef][Medline] [Order article via Infotrieve]
34. Quesada, I., Chin, W.-C., Steed, J., Campos-Bedolla, P., and Verdugo, P. (2001) Biophys. J. 80, 2133-2139[Medline] [Order article via Infotrieve]
35. Hagn, C., Schmid, K. W., Firscher-Colbrie, R., and Winkler. (1986) Lab. Invest. 55, 405-411[Medline] [Order article via Infotrieve]
36. Gill, B. M., Barbosa, J. A., Dinh, T. Q., Garrod, S., and O`Connor, D. T. (1991) Regul. Pept. 33, 223-235[CrossRef][Medline] [Order article via Infotrieve]
37. Yoo, S. H., and Albanesi, J. P. (1991) J. Biol. Chem. 266, 7740-7745[Abstract/Free Full Text]
38. Yoo, S. H., and Jeon, C. J. (2000) J. Biol. Chem. 275, 15067-15073[Abstract/Free Full Text]
39. Thrower, E. C., Park, H. Y., Yoo, S. H., and Ehrlich, B. (2001) Biophys. J. 80, 455[Medline] [Order article via Infotrieve].a
40. Murphy, S. M., Pilowsky, P. M., and Llewellyn-Smith, I. J. (1998) J. Histochem. Cytochem. 46, 1261-1268[Abstract/Free Full Text]
41. Spector, D. L., Fu, X. D., and Maniatis, T. (1991) EMBO J. 10, 3467-3481[Medline] [Order article via Infotrieve]
42. Kang, Y. K., and Yoo, S. H. (1997) FEBS Lett. 404, 87-90[CrossRef][Medline] [Order article via Infotrieve]
43. Yoo, S. H., and Kang, Y. K. (1997) FEBS Lett. 406, 259-262[CrossRef][Medline] [Order article via Infotrieve]
44. Yoo, S. H. (1995) J. Biol. Chem. 270, 12578-12583[Abstract/Free Full Text]
45. Scatchard, G. (1989) Ann. N. Y. Acad. Sci. 51, 660-672[CrossRef]
46. Matter, N., Ritz, M.-F., Freyermuth, S., Rogue, P., and Malviya, A. (1993) J. Biol. Chem. 268, 732-736[Abstract/Free Full Text]
47. Gerasimenko, O. V., Gerasimenko, J. V., Tepikin, A. V., and Petersen, O. H. (1995) Cell 80, 439-444[CrossRef][Medline] [Order article via Infotrieve]
48. Thorn, P., Lawrie, A. M., Smith, P. M., Gallacher, D. V., and Petersen, O. H. (1993) Cell 74, 661-668[CrossRef][Medline] [Order article via Infotrieve]
49. Kasai, H., and Petersen, O. H. (1994) Trends Neurosci. 17, 95-101[CrossRef][Medline] [Order article via Infotrieve]
50. Kern, H. F. (1993) in The Pancreas: Biology, Pathobiology and Disease (Go, V. L. W., ed), 2nd Ed. , pp. 9-19, Raven Press, New York
51. Mignery, G. A., and Südhof, T. C. (1990) EMBO J. 9, 3893-3898[Medline] [Order article via Infotrieve]
52. Yoo, S. H., and Lewis, M. S. (1992) J. Biol. Chem. 267, 11236-11241[Abstract/Free Full Text]
53. Thiele, C., and Huttner, W. B. (1998) J. Biol. Chem. 273, 1223-1231[Abstract/Free Full Text]
54. Yoo, S. H., and Lewis, M. S. (1996) J. Biol. Chem. 271, 17041-17046[Abstract/Free Full Text]
55. Johnson, S., Michalak, M., Opas, M., and Eggleton, P. (2001) Trends Cell Biol. 11, 122-129[CrossRef][Medline] [Order article via Infotrieve]
56. Ostwald, T. J., and MacLennan, D. H. (1974) J. Biol. Chem. 249, 974-979[Abstract/Free Full Text]
57. Treves, S., De Mattei, M., Lanfredi, M., Villa, A., Green, N. M., MacLennan, D. H., Meldolesi, J., and Pozzan, T. (1990) Biochem. J. 271, 473-480[Medline] [Order article via Infotrieve]
58. Baksh, S., and Michalak, M. (1991) J. Biol. Chem. 266, 21458-21465[Abstract/Free Full Text]
59. Meldolesi, J., and Pozzan, T. (1998) Trends Biochem. Sci. 23, 10-14[CrossRef][Medline] [Order article via Infotrieve]


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
S. Kang, J. Kang, H. Kwon, D. Frueh, S. H. Yoo, G. Wagner, and S. Park
Effects of Redox Potential and Ca2+ on the Inositol 1,4,5-Trisphosphate Receptor L3-1 Loop Region: IMPLICATIONS FOR RECEPTOR REGULATION
J. Biol. Chem., September 12, 2008; 283(37): 25567 - 25575.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
F. M. Heidrich, K. Zhang, M. Estrada, Y. Huang, F. J. Giordano, and B. E. Ehrlich
Chromogranin B Regulates Calcium Signaling, Nuclear Factor {kappa}B Activity, and Brain Natriuretic Peptide Production in Cardiomyocytes
Circ. Res., May 23, 2008; 102(10): 1230 - 1238.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
C.-u. Choe and B. E. Ehrlich
The Inositol 1,4,5-Trisphosphate Receptor (IP3R) and Its Regulators: Sometimes Good and Sometimes Bad Teamwork
Sci. Signal., November 28, 2006; 2006(363): re15 - re15.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. L. Garcia, S.-K. Han, W. G. Janssen, Z. Z. Khaing, T. Ito, M. J. Glucksman, D. L. Benson, and S. R. J. Salton
A Prohormone Convertase Cleavage Site within a Predicted {alpha}-Helix Mediates Sorting of the Neuronal and Endocrine Polypeptide VGF into the Regulated Secretory Pathway
J. Biol. Chem., December 16, 2005; 280(50): 41595 - 41608.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
E.-M. Hur, Y.-S. Park, Y. H. Huh, S. H. Yoo, K.-C. Woo, B.-H. Choi, and K.-T. Kim
Junctional membrane inositol 1,4,5-trisphosphate receptor complex coordinates sensitization of the silent EGF-induced Ca2+ signaling
J. Cell Biol., May 23, 2005; 169(4): 657 - 667.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C.-U. Choe, K. D. Harrison, W. Grant, and B. E. Ehrlich
Functional Coupling of Chromogranin with the Inositol 1,4,5-Trisphosphate Receptor Shapes Calcium Signaling
J. Biol. Chem., August 20, 2004; 279(34): 35551 - 35556.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. C. Thrower, C. U. Choe, S. H. So, S. H. Jeon, B. E. Ehrlich, and S. H. Yoo
A Functional Interaction between Chromogranin B and the Inositol 1,4,5-Trisphosphate Receptor/Ca2+ Channel
J. Biol. Chem., December 12, 2003; 278(50): 49699 - 49706.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. H. Huh, S. H. Jeon, and S. H. Yoo
Chromogranin B-induced Secretory Granule Biogenesis: COMPARISON WITH THE SIMILAR ROLE OF CHROMOGRANIN A
J. Biol. Chem., October 17, 2003; 278(42): 40581 - 40589.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
F. Thevenod
Ion channels in secretory granules of the pancreas and their role in exocytosis and release of secretory proteins
Am J Physiol Cell Physiol, September 1, 2002; 283(3): C651 - C672.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. H. Yoo, S. H. You, M. K. Kang, Y. H. Huh, C. S. Lee, and C. S. Shim
Localization of the Secretory Granule Marker Protein Chromogranin B in the Nucleus. POTENTIAL ROLE IN TRANSCRIPTION CONTROL
J. Biol. Chem., May 3, 2002; 277(18): 16011 - 16021.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/49/45806    most recent
M107532200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yoo, S. H.
Right arrow Articles by Park, H. Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yoo, S. H.
Right arrow Articles by Park, H. Y.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement